Artificial intelligence is no longer a futuristic concept; it’s a present-day reality, rapidly transforming industries and reshaping the global economic landscape. As AI continues its exponential ...

Businesses can expect significant efficiency gains with AI’s ability to streamline processes, enhance decision-making and ...

It is safe to say in 2025 that the best job in the world is the chief executive officer of Nvidia, and that the company’s ...

AstraZeneca will acquire all outstanding equity of EsoBiotec for a total consideration of up to $1bn, on a cash and debt free basis. This will include an initial payment of $425m on deal closing, and ...

Q2 2025 Earnings Call Transcript March 20, 2025 Micron Technology, Inc. beats earnings expectations. Reported EPS is $1.56, ...

Andes Technology was a visionary early-adopter of RISC-V. Through continuous innovation, strong customer orientation, and a deep understanding of market trends, the company has gained momentum, ...

Q2 2025 Results Conference Call March 20, 2025 4:30 PM ET. Company Participants. Satya Kumar - Corporate Vice President, Investor Relations and ...

Expert analyst Josh Bersin predicts AI-driven systems will soon accelerate recruiting and enable more informed decisions.

Operator Thank you for standing by, and welcome to Micron's second quarter 2025 financial call. At this time, all participants are in listen-only mode. After the speakers' presentation, there will be ...

Andes Technology Corporation (TWSE: 6533), a global leader in high-performance, low-power RISC-V processor IP solutions, has achieved a significant milestone ...

AstraZeneca to acquire EsoBiotec to advance cell therapy ambition Acquisition includes world-leading in vivo delivery platform with potential to transform cell therapy AstraZeneca has ...